This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignees: Centre Hospitalier Régional Universitaire De Tours, National Institute of Health and Medical Research, Universite De Tours. Active years: 2014-2020.
Company Filing History:
1 out of 5 
1 out of 1,853 
1 out of 19 Years Active: 2014-2020
Title: Romuald Patient: Innovator in Biopharmaceuticals
Introduction
Romuald Patient, based in Joue-les-Tours, France, is a notable inventor in the biopharmaceutical field with a focus on vaccine development. He holds two patents that showcase his innovative approaches to creating immunogenic fusion proteins aimed at combating serious viral diseases.
Latest Patents
Romuald Patient's latest patents include significant advancements in the field of vaccine preparation. One patent, titled "Fusion proteins and use thereof for preparing vaccines," describes an immunogenic fusion protein comprising two specific peptides. The first peptide is derived from the human hepatitis B virus (HBV), while the second involves sequences from the Zika virus envelope protein. This innovative combination aims to enhance the efficacy of vaccines against emerging viral threats.
Another notable patent by Patient is focused on hepatitis C vaccine development. Titled "Fusion proteins and use thereof for preparing hepatitis C vaccines," this patent outlines an immunogenic fusion protein that features a peptide from the hepatitis B virus and an envelope protein from a hepatitis C virus isolate. His work includes hybrid nucleic acid molecules and vectors that are designed to improve the production and effectiveness of the proposed vaccines.
Career Highlights
Romuald Patient's career has been significantly shaped by his roles at reputable institutions, including the Université François-Rabelais de Tours and Université de Tours. His dedication to research and innovation in virology has established him as a key figure in his field and has contributed to advancements in vaccine technology.
Collaborations
Throughout his career, Patient has collaborated with esteemed colleagues, including Philippe Roingeard and Christophe Hourioux. These collaborations have further enriched his research and have led to the development of new ideas and technologies in the biopharmaceutical sector.
Conclusion
Romuald Patient stands out as an accomplished inventor whose work has the potential to make significant contributions to public health through innovative vaccine solutions. His patents reflect a deep commitment to addressing viral diseases and enhancing global health outcomes.